Academic Bibliography

 Search 200 years of publications by Ghent University researchers.
Advanced search
2 files | 1.84 MB
Add to list
  1. Search results
  2. Neonatal magnesium levels are safe af...

Neonatal magnesium levels are safe after maternal MgSO4 administration : a comparison between unexposed preterm neonates and neonates exposed for fetal neuroprotection or maternal eclampsia prevention : a cohort study

Isabelle Dehaene (UGent) , Tessa Van Steenstraeten (UGent) , Kris De Coen (UGent) , Stefanie De Buyser (UGent) , Johan Decruyenaere (UGent) , Koenraad Smets (UGent) and Kristien Roelens (UGent)
(2022) EUROPEAN JOURNAL OF PEDIATRICS. 181(8). p.2971-2980
Author
Organization
Abstract
To objective of this study was to compare neonatal magnesemia in the first 15 days of neonatal life between three groups: a control group not exposed to MgSO4, a neuroprotection group, and an eclampsia prevention group, and to explore its associations with child outcomes. A retrospective single-centre cohort study was performed in a tertiary care setting. Infants admitted at the neonatal intensive care unit born between 24 and 32 weeks' gestation, regardless of etiology of preterm birth, were included. The mean outcome measure was neonatal magnesemia (mmol/L). Linear mixed regression of neonatal magnesemia on exposure group and day of life was done. Generalised estimating equation models of child outcomes on neonatal magnesemia according to exposure group and day of life were made. The analyses showed that in neonatal magnesemia is significantly higher in the preeclampsia group compared to the control and neuroprotection groups. On the day of birth, this is irrespective of maternal magnesemia (preeclampsia vs control groups), and the maternal total dose or duration of MgSO4 administration (preeclampsia vs neuroprotection group). No differences were found in short-term composite outcome between the three groups. Conclusion: We found mean differences in neonatal magnesemia between children not exposed to MgSO4 antenatally, children exposed for fetal neuroprotection, and children exposed for maternal eclampsia prevention. A 4-g loading and 1-g/h maintenance doses, for fetal neuroprotection and eclampsia prevention, appear to be safe on the short term for the neonate.
Keywords
Preterm birth, Preeclampsia, Neuroprotection, Neonatal magnesemia, SULFATE EXPOSURE, MAGPIE TRIAL, OUTCOMES, INFANTS, BIRTH, PREECLAMPSIA, PLACEBO, BRAIN

Downloads

  • Download
    (...).pdf
    • full text (Published version)
    • |
    • UGent only
    • |
    • PDF
    • |
    • 852.89 KB
  • Download
    Neonatal magnesemia EJoP 220415 aam.pdf
    • full text (Accepted manuscript)
    • |
    • open access
    • |
    • PDF
    • |
    • 989.51 KB

Citation

Please use this url to cite or link to this publication:

MLA
Dehaene, Isabelle, et al. “Neonatal Magnesium Levels Are Safe after Maternal MgSO4 Administration : A Comparison between Unexposed Preterm Neonates and Neonates Exposed for Fetal Neuroprotection or Maternal Eclampsia Prevention : A Cohort Study.” EUROPEAN JOURNAL OF PEDIATRICS, vol. 181, no. 8, 2022, pp. 2971–80, doi:10.1007/s00431-022-04507-7.
APA
Dehaene, I., Van Steenstraeten, T., De Coen, K., De Buyser, S., Decruyenaere, J., Smets, K., & Roelens, K. (2022). Neonatal magnesium levels are safe after maternal MgSO4 administration : a comparison between unexposed preterm neonates and neonates exposed for fetal neuroprotection or maternal eclampsia prevention : a cohort study. EUROPEAN JOURNAL OF PEDIATRICS, 181(8), 2971–2980. https://doi.org/10.1007/s00431-022-04507-7
Chicago author-date
Dehaene, Isabelle, Tessa Van Steenstraeten, Kris De Coen, Stefanie De Buyser, Johan Decruyenaere, Koenraad Smets, and Kristien Roelens. 2022. “Neonatal Magnesium Levels Are Safe after Maternal MgSO4 Administration : A Comparison between Unexposed Preterm Neonates and Neonates Exposed for Fetal Neuroprotection or Maternal Eclampsia Prevention : A Cohort Study.” EUROPEAN JOURNAL OF PEDIATRICS 181 (8): 2971–80. https://doi.org/10.1007/s00431-022-04507-7.
Chicago author-date (all authors)
Dehaene, Isabelle, Tessa Van Steenstraeten, Kris De Coen, Stefanie De Buyser, Johan Decruyenaere, Koenraad Smets, and Kristien Roelens. 2022. “Neonatal Magnesium Levels Are Safe after Maternal MgSO4 Administration : A Comparison between Unexposed Preterm Neonates and Neonates Exposed for Fetal Neuroprotection or Maternal Eclampsia Prevention : A Cohort Study.” EUROPEAN JOURNAL OF PEDIATRICS 181 (8): 2971–2980. doi:10.1007/s00431-022-04507-7.
Vancouver
1.
Dehaene I, Van Steenstraeten T, De Coen K, De Buyser S, Decruyenaere J, Smets K, et al. Neonatal magnesium levels are safe after maternal MgSO4 administration : a comparison between unexposed preterm neonates and neonates exposed for fetal neuroprotection or maternal eclampsia prevention : a cohort study. EUROPEAN JOURNAL OF PEDIATRICS. 2022;181(8):2971–80.
IEEE
[1]
I. Dehaene et al., “Neonatal magnesium levels are safe after maternal MgSO4 administration : a comparison between unexposed preterm neonates and neonates exposed for fetal neuroprotection or maternal eclampsia prevention : a cohort study,” EUROPEAN JOURNAL OF PEDIATRICS, vol. 181, no. 8, pp. 2971–2980, 2022.
@article{01H4DSP8A852G8J6KSPWZFK20R,
  abstract     = {{To objective of this study was to compare neonatal magnesemia in the first 15 days of neonatal life between three groups: a control group not exposed to MgSO4, a neuroprotection group, and an eclampsia prevention group, and to explore its associations with child outcomes. A retrospective single-centre cohort study was performed in a tertiary care setting. Infants admitted at the neonatal intensive care unit born between 24 and 32 weeks' gestation, regardless of etiology of preterm birth, were included. The mean outcome measure was neonatal magnesemia (mmol/L). Linear mixed regression of neonatal magnesemia on exposure group and day of life was done. Generalised estimating equation models of child outcomes on neonatal magnesemia according to exposure group and day of life were made. The analyses showed that in neonatal magnesemia is significantly higher in the preeclampsia group compared to the control and neuroprotection groups. On the day of birth, this is irrespective of maternal magnesemia (preeclampsia vs control groups), and the maternal total dose or duration of MgSO4 administration (preeclampsia vs neuroprotection group). No differences were found in short-term composite outcome between the three groups.

Conclusion: We found mean differences in neonatal magnesemia between children not exposed to MgSO4 antenatally, children exposed for fetal neuroprotection, and children exposed for maternal eclampsia prevention. A 4-g loading and 1-g/h maintenance doses, for fetal neuroprotection and eclampsia prevention, appear to be safe on the short term for the neonate.}},
  author       = {{Dehaene, Isabelle and Van Steenstraeten, Tessa and De Coen, Kris and De Buyser, Stefanie and Decruyenaere, Johan and Smets, Koenraad and Roelens, Kristien}},
  issn         = {{0340-6199}},
  journal      = {{EUROPEAN JOURNAL OF PEDIATRICS}},
  keywords     = {{Preterm birth,Preeclampsia,Neuroprotection,Neonatal magnesemia,SULFATE EXPOSURE,MAGPIE TRIAL,OUTCOMES,INFANTS,BIRTH,PREECLAMPSIA,PLACEBO,BRAIN}},
  language     = {{eng}},
  number       = {{8}},
  pages        = {{2971--2980}},
  title        = {{Neonatal magnesium levels are safe after maternal MgSO4 administration : a comparison between unexposed preterm neonates and neonates exposed for fetal neuroprotection or maternal eclampsia prevention : a cohort study}},
  url          = {{http://doi.org/10.1007/s00431-022-04507-7}},
  volume       = {{181}},
  year         = {{2022}},
}
Altmetric
View in Altmetric
Web of Science
Times cited: